Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01110187 · ClinicalTrials.gov registry record · NA
A Pilot Study of NSICU Assessment of Seizure Prophylaxis With Lacosamide
A NA study, sponsored by University of Alabama at Birmingham.
- Terminated
- Registry status
- NA
- Development phase
- 11
- Enrollment target
NCT01110187 is a NA study that was terminated before completion, run by University of Alabama at Birmingham. The registered enrollment target is 11 participants.
The verdict
NCT01110187, a NA study, was terminated before completion, sponsored by University of Alabama at Birmingham.
- TERMINATED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
Study Summary
Trial to determine if seizure prophylaxis with IV LCM in NSICU patients experiencing mental status changes due to severe traumatic brain injury (sTBI) will result in improved short- and long-term outcomes and better immediate adverse effects when compared to the current standard of care anticonvulsant (IV fPHT) and will be at least as effective as IV fPHT in preventing clinical and sub-clinical seizure activity.
Interventions
- DRUG lacosamide
- DRUG Fosphenytoin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2010-05 |
| Est. Completion | 2012-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01110187
The ClinicalTrials.gov registry entry for NCT01110187 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which lacosamide is the first listed.
NCT01110187 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01110187 about?
NCT01110187 is a clinical study titled "A Pilot Study of NSICU Assessment of Seizure Prophylaxis With Lacosamide". Trial to determine if seizure prophylaxis with IV LCM in NSICU patients experiencing mental status changes due to severe traumatic brain injury (sTBI) will result in improved short- and long-term outcomes and better immediate adverse effects when compared to the current standard of care anticonvulsa...
What is the current status of trial NCT01110187?
This trial is currently terminated. It is a NA study. The enrollment target is 11 participants. The study started on 2010-05. Estimated completion is 2012-05.
What interventions are being tested in trial NCT01110187?
The interventions under investigation include: lacosamide (DRUG), Fosphenytoin (DRUG).
Who is sponsoring clinical trial NCT01110187?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.